Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Opioid use disorder genetic risk variant detection system and collection kit

Número de PMA: P230032 · 2026-05-20

SolicitanteAutoGenomics, Inc.
Fecha de decisión2026-05-20
Número PMAP230032
Código de productoQZH
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorTX

Resumen del dispositivo

Opioid use disorder genetic risk variant detection system and collection kit is the device name listed in this FDA 510(k) record. The listed applicant is AutoGenomics, Inc.. It received FDA 510(k) clearance on 2026-05-20. The device is classified under product code QZH. It was reviewed by the TX advisory panel.

Preguntas frecuentes

What is the Opioid use disorder genetic risk variant detection system and collection kit?

Opioid use disorder genetic risk variant detection system and collection kit is a medical device that received FDA 510(k) clearance on 2026-05-20. The listed applicant is AutoGenomics, Inc..

When did Opioid use disorder genetic risk variant detection system and collection kit receive FDA 510(k) clearance?

The clearance date for Opioid use disorder genetic risk variant detection system and collection kit can be found in the official FDA records.

Who is the listed applicant for Opioid use disorder genetic risk variant detection system and collection kit?

The FDA 510(k) record lists AutoGenomics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Opioid use disorder genetic risk variant detection system and collection kit?

The FDA product code for Opioid use disorder genetic risk variant detection system and collection kit is QZH.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑